A Two Week Study to Assess the Tolerability of AZD9668 in Chronic Obstructive Pulmonary Disease (COPD) Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG

AZD9668

30mg oral tablets twice daily (bid) for 14 days

DRUG

Placebo

Matched placebo to 30mg oral tablet twice daily (bid) for 14 days

Trial Locations (1)

Research Site, Berlin